Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Individual theophylline dosing based on bioelectrical impedance analysis

J S Sidhu1, E J Triggs, B G Charles

  • 1Department of Pharmacy, University of Queensland, Australia.

British Journal of Clinical Pharmacology
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global diversity analysis of plant-associated <i>Pseudopithomyces</i> fungi reveals a new species producing the toxin associated with facial eczema in livestock: <i>Pseudopithomyces toxicarius sp. nov</i>.

Studies in mycology·2026
Same author

The effect of breastmilk and saliva combinations on the in vitro growth of oral pathogenic and commensal microorganisms.

Scientific reports·2018
Same author

Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma.

Leukemia·2017
Same author

Treatment of chronic hepatitis C genotype 3 with Sofosbuvir-based therpy: a real-life study.

Hepatology international·2017
Same author

Deep sequencing of the 16S ribosomal RNA of the neonatal oral microbiome: a comparison of breast-fed and formula-fed infants.

Scientific reports·2016
Same author

Disability in brisbane caused by chronic disease.

The Australian journal of physiotherapy·2014

Bioelectrical impedance (BI) analysis offers a viable method for determining slow-release theophylline dosage. BI-guided dosing showed comparable results to weight-based dosing for steady-state theophylline concentrations.

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Biomedical Engineering
  • Clinical Pharmacology

Background:

  • Accurate theophylline dosing is crucial for therapeutic efficacy and minimizing toxicity.
  • Traditional weight-based dosing may not account for individual physiological variations.
  • Bioelectrical impedance (BI) analysis offers a non-invasive method to assess body composition and fluid status.

Purpose of the Study:

  • To evaluate the role of bioelectrical impedance (BI) analysis in determining optimal slow-release theophylline dosage.
  • To compare theophylline dosage and resulting steady-state concentrations (Css,pre) determined by BI analysis versus traditional body weight-based methods.
  • To identify key BI parameters predictive of theophylline Css,pre.

Main Methods:

  • Fifteen healthy subjects received a standard 200 mg dose of slow-release theophylline.

Related Experiment Videos

  • Bioelectrical impedance (BI) analysis was performed to obtain parameters like reactance and resistance.
  • Theophylline dosage was determined using both body weight and BI analysis.
  • Pre-dose, steady-state theophylline concentrations (Css,pre) were measured and compared between the two dosing methods.

    • Main Results:

    • Reactance and l/resistance from BI analysis were significant predictors of pre-dose, steady-state theophylline concentrations.
    • Theophylline doses determined by BI analysis (9.6 +/- 2.4 mg kg-1 day-1) were less biased (mean prediction error = 0.6) than weight-based doses (8.8 mg kg-1 day-1).
    • BI-guided dosing was slightly less precise (mean squared error = 7.1) compared to weight-based dosing (mean squared error = 6.3), but these differences were not statistically significant (P > 0.05).

    Conclusions:

    • Bioelectrical impedance (BI) analysis is a potentially useful tool for guiding slow-release theophylline dosage.
    • BI-guided theophylline dosing demonstrates comparable efficacy and safety to traditional weight-based methods.
    • Further research is warranted to optimize BI parameters for individualized drug dosing.